Dr. Pinder-Schenck is a medical oncologist and researcher at the H Lee Moffitt Cancer Center and Research Institute of Tampa, Florida. She specializes in the treatment of patients with lung cancer and other thoracic malignancies. Dr. Pinder-Schenck received her MD from Stanford University School of Medicine in Stanford, California She completed her internship and residency in internal medicine at the University of North Carolina in Chapel Hill, North Carolina. Dr. Pinder-Schenck then accepted a fellowship in oncology at the M.D. Anderson Cancer Center in Houston, Texas.
Dr. Pinder-Schenck has served as the principal investigator on numerous clinical trials for patients with lung cancer. She is interested in all aspects of the clinical care of patients with lung cancer. Dr. Pinder-Schenck serves on the National Comprehensive Cancer Network Lung Cancer Committee, helping to develop guidelines for the diagnosis and treatment of lung cancer. Her research focuses on identifying novel biomarkers and therapies for patients with lung cancer. She has been awarded a grant to study molecular testing in lung cancer. Dr. Pinder-Schenck has a special interest in lung cancer in women.